Aptose Biosciences Inc (APS) — Cash Flow Reinvestment Rate
Latest as of March 1999:
0.00x
Aptose Biosciences Inc (APS) has a Cash Flow Reinvestment Rate of 0.00x as of March 1999, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$210.12K. See APS equity financing ratio to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
CA$0.00
Capex + Investments
Operating Cash Flow
CA$210.12K
CAD
Capital Expenditures
CA$0.00
CAD
Annual Cash Flow Reinvestment Rate for Aptose Biosciences Inc (None–None)
Year-by-year capital reinvestment analysis for Aptose Biosciences Inc. For live market cap and broader valuation context, see Aptose Biosciences Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow